OOIR: Observatory of International Research

Papers

(The TQCC of Climacteric is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Use of aromatase inhibitors in menopausal deep endometriosis: a case report and literature review	118
Scientific insights into brain fog during the menopausal transition	68
Understanding of and clinical approach to cardiometabolic transition at the menopause	58
Expanding knowledge across medical specialties in menopause research and practice: why it is so important for women’s health	43
Association between testosterone and cognitive performance in postmenopausal women: a systematic review of observational studies	36
Presidential reflections: how we got here, where we might go	32
Treatment of women with BRCA mutation	30
The impact of micronized progesterone on cardiovascular events – a systematic review	28
Evidence synthesis in the time of COVID-19	27
Hormone therapy for postmenopausal osteoporosis management	22
Postmenopausal hyperandrogenism	21
Safety and acceptability of intravaginal rings releasing estradiol and progesterone	21
Management of menopause: a survey of physicians from the Middle East and Africa	20
Neuroprotective effect of hormone replacement therapy: a review of the literature	19
Short-term effects of an erbium/neodymium laser combination in superficial dyspareunia: a pilot study	19
Perimenopause in women with rheumatologic diseases: a spotlight on an under-addressed transition	18
Fezolinetant for VMS: a balanced view on efficacy and safety needed – author’s reply	18
Impacts of menopause hormone therapy on mood disorders among postmenopausal women	17
Translation and validation of the Depression Anxiety Stress Scales for menopausal women in Indonesia	17
The role of medications in successful aging	17
Menopausal hormone therapy: why we should no longer be afraid of the breast cancer risk	16
Low genitourinary tract risks in women living with the human immunodeficiency virus	14
Vaginal collagen I and III changes after carbon dioxide laser application in postmenopausal women with the genitourinary syndrome: a pilot study	14
Three-dimensional bioprinting of artificial ovaries by an extrusion-based method using gelatin-methacryloyl bioink	13
God, spirituality and religion in women dying from gynecological cancer	12

Telemedicine and women’s health	12
Are we assessing genitourinary syndrome of menopause properly?	12
Pelvic floor muscle rehabilitation for genitourinary syndrome of menopause: why, how and when?	12
Effects of ospemifene on overactive bladder in postmenopausal women with vulvovaginal atrophy	11
Testosterone and the heart: friend or foe?	11
Bone health 2022: an update	11
Vaginal microbiome of women with premature ovarian insufficiency: a descriptive cross-sectional study	11
Long-term clinical and histological safety and efficacy of the CO ₂ laser for treatment of genitourinary syndrome of menopause: an original study	10
Ischemia but no obstructive coronary artery disease: more than meets the eye	10
A pilot screening study for low bone mass in Singaporean women using years since menopause and BMI	10
Use of MHT in women with cardiovascular disease: a systematic review and meta-analysis	10
Pregnancy-associated risk factors for future cardiovascular disease – early prevention strategies warranted	10
Primary choice of estrogen and progestogen as components for HRT: a clinical pharmacological view	9
Postmenopausal women’s cognitive function and performance of virtual reality tasks	9
Vitamin D inadequacy combined with high BMI affects paraspinal muscle atrophy and pain intensity in postmenopausal women	9
FNDC5/Irisin polymorphisms are associated with osteopenia in postmenopausal Mayan-Mestizo women	9
Low thrombin generation in postmenopausal women using estetrol	9
Alterations of regional homogeneity in perimenopause: a resting-state functional MRI study	9
Early decrease in lean mass and bone mass in postmenopausal women: a cross-sectional study	9
Allelic variants of the estrogen receptor genes and frailty phenotype in postmenopausal women	9
Obesity and sexual health: focus on postmenopausal women	8
Psychometric properties of the French Hot Flash Related Daily Interference Scale (HFRDIS)	8
Endometriosis-associated cancer	8
Genitourinary symptoms and sexual function in women with primary ovarian insufficiency	8
Correction	8
Menopause hormone treatment after cancer	8
New insights into the diagnosis and management of bone health in premature ovarian insufficiency	8
Effects of resistance training on quality of life in postmenopausal women with vasomotor symptoms	8
The yin and yang of GSM and low sexual desire	8
The promotion of menopausal hormone therapy might be determined by the attitude of health-care professionals	7
Intravenous administration of mitochondria improves ovarian function by anti-apoptosis in the premature ovarian insufficiency model	7
Isoflavones obtained from red clover improve both dyslipidemia and menopausal symptoms in menopausal women: a prospective randomized placebo-controlled trial	7
Estrogen as a guardian of auditory health: Tsp1–CD47 axis regulation and noise-induced hearing loss	7
Safety of prasterone in breast cancer survivors treated with aromatase inhibitors: the VIBRA pilot study	7
Peer reviewers for Climacteric in 2024	7
Changes to health screening – we need to remain vigilant	7
Estrone, sex hormone binding globulin and lipid profiles in older women: an observational study	7
Fracture risk assessment by the FRAX model	7
Association of bilateral oophorectomy and menopause hormone therapy with mild cognitive impairment: the REDLINC X study	7
Lichen sclerosus of the vulva	7
Peer reviewers for Climacteric in 2022	6
Lack of evidence that progesterone in ovulatory cycles causes breast cancer	6
Menopause symptoms, sexual dysfunctions and pelvic floor disorders in refugee and asylum seeker women: a scoping review	6
Breast cancer genetics and risk assessment: an overview for the clinician	6
Relationship between menopausal hormone therapy and incidence of fractures in postmenopausal women	6
Arthralgia in midlife Singaporean women: the Integrated Women’s Health Program (IWHP)	6
Prevalence, impact and management of postmenopausal symptoms among postmenopausal women in Rwanda	6
Update on bone health: the International Menopause Society White Paper 2021	6
Pharmacokinetics, safety and preliminary pharmacodynamic evaluation of DARE-VVA1: a soft gelatin capsule containing tamoxifen for the treatment of vulvovaginal atrophy	6
Postmenopausal hormone therapy in prior pre-eclamptic women: a nationwide cohort study in Finland	6

Ethnicity in polycystic ovary syndrome	6
Effectiveness and safety of menopause treatments: pitfalls of available evidence and future research need	6
Selective estrogen receptor modulators and bone health	6
Progress in understanding and management of premature ovarian insufficiency	6
Premature ovarian insufficiency and autoimmune profiles: a prospective case–control study	6
Recent advances in the management of postmenopausal women with non-atypical endometrial hyperplasia	6
Fezolinetant for the treatment of vasomotor symptoms associated with menopause: a meta-analysis	5
Evaluation of the relationship between homocysteine levels and bone mineral density in postmenopausal women	5
Real-world clinical evaluation of natural and induced vasomotor symptoms in the USA and Europe	5
Acupuncture and Chinese herbal medicine for menopausal mood disorder: a randomized controlled trial [Letter]	5
Therapeutic effects of curculigoside on cyclophosphamide-induced premature ovarian failure in mice	5
Population-based survey on menopausal symptoms and treatment use	5
Vaginal dryness: a review of current understanding and management strategies	5
Closing the gap: cardiovascular disease in women	5
In search of a well-balanced narrative of the menopause momentum	5
Quality of life in menopausal women in the workplace – a systematic review	5
Informal Invitation from Climacteric	5